Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AN2 Therapeutics, Inc. - Common Stock (NQ:ANTX)

1.210 -0.050 (-3.97%)
Streaming Delayed Price Updated: 10:55 AM EDT, Sep 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AN2 Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
81 Biggest Movers From Yesterday
Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results. 
Via Benzinga
AN2 Therapeutics Appoints Maggie FitzPatrick to Its Board of Directors
From AN2 Therapeutics, Inc.
Via Business Wire
RA Capital-Backed AN2 Therapeutics Hits NASDAQ, With IPO Price At $15
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2022
Upgrades 
Via Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting... 
Via Benzinga
Opening Day: AN2 Therapeutics Rises In Public Debut After Upsized IPO
Shares of AN2 Therapeutics rose over 15% in its trading debut on Friday following an upsized initial public offering. This was only the second initial public offering this month, as the IPO market... 
Via Talk Markets
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Preview: An2 Therapeutics, Inc Set To IPO Tomorrow
AN2 Therapeutics, Inc (NASDAQ:ANTX) IPO will take place March, 25 on the NASDAQ exchange under the ticker ANTX. The company is offering shares at an expected price between $14.00... 
Via Benzinga
Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment
Via FinancialNewsMedia
Topics Death
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.